- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on AML Including AML de Novo and AML Secondary to MDS in Australia
Total 188 results
-
Sydney South West Area Health ServiceUnknownCoronary Angioplasty and Stenting | Single de Novo Coronary Artery StenosesAustralia
-
University of LeipzigDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingMDS | MDS/MPNGermany, Austria
-
Novartis PharmaceuticalsCompletedSubfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMDAustralia
-
Hoffmann-La RocheRecruitingChoroidal Neovascularization Secondary to Pathologic MyopiaKorea, Republic of, China, Australia, Singapore, Poland, France, Germany, Italy, Taiwan, Hong Kong, Spain
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
NovartisCompletedSubfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
Otsuka Australia Pharmaceutical Pty LtdCompletedMyelodysplastic Syndrome (MDS)Australia
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
University of AdelaideUniversity of South AustraliaUnknown
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Apellis Pharmaceuticals, Inc.Active, not recruitingGeographic Atrophy Secondary to Age-related Macular DegenerationUnited States, Netherlands, France, Israel, Germany, United Kingdom, Canada, Czechia, Australia, Spain, Italy, Argentina, Brazil, New Zealand, Poland
-
CardiosonicUnknownHypertension, Resistant to Conventional TherapyAustralia
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Medical University of GrazActive, not recruitingSecondary Sclerosing CholangitisAustria
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Ludwig Boltzmann Institute for Digital Health and...REHA Zentrum Salzburg; Reha-Klinik MontafonActive, not recruitingCardiovascular Diseases | Cardiac Rehabilitation | Secondary PreventionAustria
-
Medical University of GrazRecruitingSecondary Sclerosis Cholangitis in Critically Ill PatientsAustria
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingNeuroendocrine Tumors Metastatic to the LiverAustralia
-
BayerRegeneron PharmaceuticalsRecruitingMacular Edema Secondary to Retinal Vein OcclusionKorea, Republic of, Japan, China, Lithuania, United States, Italy, Spain, Hungary, Israel, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Germany, Latvia, Mal... and more
-
Bod AustraliaWoolcock Institute of Medical ResearchCompletedInsomnia | Sleep Disturbance | Insomnia Type; Sleep Disorder | Insomnia, Transient | Insomnia Due to Anxiety and Fear | Insomnia Due to Other Mental DisorderAustralia
-
Telethon Kids InstituteMenzies School of Health ResearchActive, not recruitingViral Gastroenteritis Due to RotavirusAustralia
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Antisoma ResearchUnknownSecondary Acute Myeloid Leukemia (Secondary AML, sAML)Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
-
Smith & Nephew, Inc.RecruitingAvascular Necrosis | Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis | Requires Correction of Functional Deformity | Requires Treatment of Fractures That Were Unmanageable Using Other TechniquesNew Zealand, Australia, Hong Kong
-
Kepler University HospitalCompletedARDS Due to Disease Caused by SARS Co-V-2Austria
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
Medical University of ViennaCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Baker Heart and Diabetes InstituteThe Alfred; Monash Medical Centre; Servier Laboratories (Australia) Pty LtdUnknownMajor Depressive Disorder (MDD)Australia
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
Ikaria Bioscience Pty LtdRecruitingTo Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other ComorbiditiesAustralia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Childhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Delenex Therapeutics AGCompletedMild-to-moderate Psoriasis VulgarisAustria, Germany
-
Medical University of GrazCompleted
-
Rainer OberbauerAmgenCompletedSecondary Hyperparathyroidism | Left Ventricular Hypertrophy | Chronic Kidney Disease Requiring Chronic DialysisAustria
-
Electra Therapeutics Inc.RecruitingSecondary Hemophagocytic Lymphohistiocytosis (sHLH)Netherlands, United States, Spain, Austria, United Kingdom, Italy
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Sydney Children's Hospitals NetworkChildren's Cancer Institute AustraliaRecruitingCancer | Neoplastic Syndromes, Hereditary | Genetic Predisposition to DiseaseAustralia
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Trans Tasman Radiation Oncology GroupAustralasian Lung Cancer Trials GroupCompletedCancer | Metastases to the LungAustralia
-
Vaxine Pty LtdFlinders Medical CentreCompletedExposure to Hepatitis B VirusAustralia
-
Medical University of GrazCompletedPregnancy Related | Cesarean Section; Complications | Adverse Reaction to Oxytocic AgentsAustria
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan